Health TrialsbyHealthPanel

Laparoscopic Surgery for Severe Recto-vaginal Endometriosis

ConditionEndometriosis Rectovaginal Septum
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
AgeNot listed
SponsorRoyal Surrey County Hospital NHS Foundation Trust

About this trial

To determine the quality of life following the radical excision of recto-vaginal endometriosis.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

All women undergoing planned surgery for severe endometriosis with bowel involvement.

Disqualifiers

Patients who declined to complete questionnaires for whatever reason and/or have their anonymous data analysed.

Trial population

Consecutive patients who underwent surgery for endometriosis with bowel involvement.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Surgery for severe endometriosis

    Procedure/Surgery

    Consecutive patients undergoing excisional surgery for severe endometriosis with bowel involvement

Treatment groups

1,000 Participants
are divided into 1 treatment group
Group A: Surgery for severe endometriosis1 intervention

Trial outcomes

Primary outcomes

1

Quality of life measured using the Endometriosis Health Profile 30 (EHP-30) and EuroQol-5 dimension (EQ-5D) questionnaires.

Recruitment is continuous

Time frame
1 year post operative
2

Bowel symptoms measured using the Gastro-intestinal Quality of Life Index (GIQLI).

Recruitment is continuous

Time frame
1 year post operative
3

Dysmenorrhoea measured using a visual analogue scale (VAS).

Recruitment is continuous

Time frame
1 year post operative
4

Dyspareunia measured using a visual analogue scale (VAS).

Recruitment is continuous

Time frame
1 year post operative

Secondary outcomes

1

Quality of life measured using the EHP-30 and EQ-5D questionnaires.

Time frame
2 months, 6 months, 5 years, 10 years, 15 years, 20 years, 25 years follow up post operative
2

Bowel symptoms were measured using GIQLI.

Time frame
2 months, 6 months, 5 years, 10 years, 15 years, 20 years, 25 years follow up post operative
3

Dysmenorrhoea measured using a visual analogue scale.

Time frame
2 months, 6 months, 5 years, 10 years, 15 years, 20 years, 25 years follow up post operative
4

Dyspareunia measured using a visual analogue scale.

Time frame
2 months, 6 months, 5 years, 10 years, 15 years, 20 years, 25 years follow up post operative

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Royal Surrey County Hospital NHS Foundation Trust

Lead sponsor

Source ClinicalTrials.gov
Apply now